Intranasal pirodavir (R77,975) treatment of rhinovirus colds

Antimicrobial Agents and Chemotherapy

Volumn 39, Issue 2, 1995, Pages 290-294

  Hayden, F G ^a   Hipskind, G J ^a   Woerner, D H ^a   Eisen, G F ^a   Janssens, M ^a   Janssen, P A J ^a   Andries, K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIRODAVIR; PLACEBO;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NOSE IRRITATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; VIRUS SHEDDING;

EID: 0028836227     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.39.2.290     Document Type: Article

References (0)